Page last updated: 2024-10-29

amrinone and Aldosteronism

amrinone has been researched along with Aldosteronism in 1 studies

Amrinone: A positive inotropic cardiotonic (CARDIOTONIC AGENTS) with vasodilator properties, phosphodiesterase 3 inhibitory activity, and the ability to stimulate calcium ion influx into the cardiac cell.
amrinone : A 3,4'-bipyridine substituted at positions 5 and 6 by an amino group and a keto function respectively. A pyridine phosphodiesterase 3 inhibitor, it is a drug that may improve the prognosis in patients with congestive heart failure.

Research Excerpts

ExcerptRelevanceReference
" Amrinone was administered to improve the features of congestive heart failure induced by retention of body fluid."3.70[General anesthesia for a patient with primary aldosteronism complicated with hypertrophic nonobstructive cardiomyopathy]. ( Kinoshita, T; Matsuda, T; Shigemi, K; Shimosato, G; Tanaka, Y, 1999)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shimosato, G1
Matsuda, T1
Shigemi, K1
Kinoshita, T1
Tanaka, Y1

Other Studies

1 other study available for amrinone and Aldosteronism

ArticleYear
[General anesthesia for a patient with primary aldosteronism complicated with hypertrophic nonobstructive cardiomyopathy].
    Masui. The Japanese journal of anesthesiology, 1999, Volume: 48, Issue:11

    Topics: Adrenal Glands; Adult; Amrinone; Anesthesia, General; Cardiomyopathy, Hypertrophic; Heart Failure; H

1999